Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francois Audibert

Showing results (11-20 of 40) with videos related to

Pageof 4
Sort By:
American Journal of Perinatology|January 19, 2013
Endothelial nitric oxide synthase gene polymorphisms and risk of preeclampsiaHui-Ping Qi, William D Fraser, Zhong-Cheng Luo, et al.
American Journal of Obstetrics and Gynecology|October 8, 2013
Plasma cotinine indicates an increased risk of preeclampsia in previous and passive smokersZhong-Cheng Luo, Pierre Julien, Shu-Qin Wei, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 15, 2014
F2-isoprostanes are correlated with trans fatty acids in the plasma of pregnant womenJessica Larose, Pierre Julien, Karine Greffard, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 21, 2013
Endostatin levels and the risk of subsequent preeclampsiaSarah Thissier-Levy, Isabelle Boucoiran, Zhong-Cheng Luo, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 10, 2026
A comparison of preeclampsia screening using clinical risk factors and the Fetal Medicine Foundation algorithmPaul Guerby, Louise Ghesquiere, Francois Audibert, et al.
BMJ Open|August 30, 2023
Expansion of non-invasive prenatal screening to the screening of 10 types of chromosomal anomalies: a cost-effectiveness analysisBounhome Soukkhaphone, Mohammad Baradaran, Ba Diep Nguyen, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|September 2, 2017
No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy OutcomesFrancois Audibert, Isabelle De Bie, Jo-Ann Johnson, et al.
Free Radical Biology & Medicine|May 23, 2015
Plasma F2-isoprostane class VI isomers at 12-18 weeks of pregnancy are associated with later occurrence of preeclampsiaJean-François Bilodeau, Shu Qin Wei, Jessica Larose, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 7, 2011
Prevention of adverse pregnancy outcomes with low-dose ASA in early pregnancy: new perspectives for future randomized trialsEmmanuel Bujold, Sylvie Tapp, Francois Audibert, et al.
American Journal of Perinatology|December 5, 2012
Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin A in singleton and multiple-gestation pregnanciesIsabelle Boucoiran, Sarah Thissier-Levy, Yuquan Wu, et al.
Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
American Journal of Perinatology|January 19, 2013
Endothelial nitric oxide synthase gene polymorphisms and risk of preeclampsiaHui-Ping Qi, William D Fraser, Zhong-Cheng Luo, et al.
American Journal of Obstetrics and Gynecology|October 8, 2013
Plasma cotinine indicates an increased risk of preeclampsia in previous and passive smokersZhong-Cheng Luo, Pierre Julien, Shu-Qin Wei, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|October 15, 2014
F2-isoprostanes are correlated with trans fatty acids in the plasma of pregnant womenJessica Larose, Pierre Julien, Karine Greffard, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 21, 2013
Endostatin levels and the risk of subsequent preeclampsiaSarah Thissier-Levy, Isabelle Boucoiran, Zhong-Cheng Luo, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 10, 2026
A comparison of preeclampsia screening using clinical risk factors and the Fetal Medicine Foundation algorithmPaul Guerby, Louise Ghesquiere, Francois Audibert, et al.
BMJ Open|August 30, 2023
Expansion of non-invasive prenatal screening to the screening of 10 types of chromosomal anomalies: a cost-effectiveness analysisBounhome Soukkhaphone, Mohammad Baradaran, Ba Diep Nguyen, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|September 2, 2017
No. 348-Joint SOGC-CCMG Guideline: Update on Prenatal Screening for Fetal Aneuploidy, Fetal Anomalies, and Adverse Pregnancy OutcomesFrancois Audibert, Isabelle De Bie, Jo-Ann Johnson, et al.
Free Radical Biology & Medicine|May 23, 2015
Plasma F2-isoprostane class VI isomers at 12-18 weeks of pregnancy are associated with later occurrence of preeclampsiaJean-François Bilodeau, Shu Qin Wei, Jessica Larose, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|June 7, 2011
Prevention of adverse pregnancy outcomes with low-dose ASA in early pregnancy: new perspectives for future randomized trialsEmmanuel Bujold, Sylvie Tapp, Francois Audibert, et al.
American Journal of Perinatology|December 5, 2012
Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin A in singleton and multiple-gestation pregnanciesIsabelle Boucoiran, Sarah Thissier-Levy, Yuquan Wu, et al.
Pageof 4